INFUSE® Bone Graft
Information for Healthcare Providers
Scott Kern, MD
Johns Hopkins University School of Medicine
Runtime: 71 minutes
Dr Scott Kern discusses the biological plausibility for a depot of rhBMP-2 to cause cancer at a distant site. In his talk, Dr Kern explains cancer pathways and how growth factors interact with those pathways. Additionally, Dr Kern reviews data for rh-BMP2 as well as current literature, and provides his conclusions on the plausibility of rh-BMP2 causing cancer.
Peter G. Whang, MD, FACS
Runtime: 14 minutes
Dr Whang discusses the science behind stem cells. In this talk, Dr Whang explores what a "real" stem cell is, which ones should be used, and what evidence exists to support their use.
David L. Cochran, DDS, PhD
Runtime: 75 minutes
Dr David Cochran, DDS, PhD, discusses the use of growth factors, specifically rhBMP-2, for tissue regeneration in the oral cavity. Dr Cochran details what growth factors are and how they work. He also shares data supporting the use of Infuse Bone Graft, and how it can be appropriately used in practice.
R. Gilbert Triplett, DDS, PhD
Runtime: 52 minutes
Dr Gilbert Triplett shares his 20+ years of experience using rh-BMP2. Dr Triplett explains some of the history of rhBMP-2 from its initial discovery by Dr Marshall Urist to the recombinant process used to manufacture rh-BMP2. He explains the benefits of the Absorbable Collagen Sponge as a carrier. Details of the prospective, multicenter, randomized controlled clinical trials supporting Infuse Bone Graft for use in OMF surgery are also discussed.